Quantification of furosemide in camel plasma by high resolution mass spectrometry,application on pharmacokinetics

We developed and validated a high‐resolution liquid chromatography mass spectrometry method for the quantification of furosemide in camel plasma which was used for a pharmacokinetic study in camels. Plasma samples were extracted by supported liquid extraction and furosemide and internal standard (furosemide‐D5) were separated on a an Agilent Zorbax XDB C₁₈ column (50 × 2.1 mm i.d., 3.5 μm). Data was acquired in full‐scan mode over a mass range of 200–400 Da in negative electrospray mode at a resolution of 70,000. Linear calibration curves were obtained over the concentration ranges of 1.0–10,000 ng/mL. The validated method was then successfully applied in evaluating the pharmacokinetics and metabolites of furosemide in six camels (Camelus dromedarus ) and we were able to advice on a withdrawal time of furosemide treatment before racing.     

Development,validation, and implementation of an UHPLC–MS/MS method for the quantitation of furosemide in infant urine samples

Furosemide is a diuretic drug used to increase urine flow in order to reduce the amount of salt and water in the body. It is commonly utilized to treat preterm infants with chronic lung disease of prematurity. There is a need for a simple and reliable quantitation of furosemide in human urine. We have developed and validated an ultra-high performance liquid chromatography–tandem mass spectrometry method for furosemide quantitation in human urine with an assay range of 0.100–50.0 μg/ml. Sample preparation involved solid-phase extraction with 10 μl of urine. Intra-day accuracies and precisions for the quality control samples were 94.5–106 and 1.86–10.2%, respectively, while inter-day accuracies and precision were 99.2–102 and 3.38–7.41%, respectively. Recovery for furosemide had an average of 23.8%, with an average matrix effect of 101%. Furosemide was stable in human urine under the assay conditions. Stability for furosemide was shown at 1 week (room temperature, 4, −20 and −78°C), 6 months (−78°C), and through three freeze–thaw cycles. This robust assay demonstrates accurate and precise quantitation of furosemide in a small volume (10 μl) of human urine. It is currently being implemented in an ongoing pediatric clinical study.     

呋塞米-Pd(Ⅱ)-碱性三苯甲烷染料反应体系的吸收光谱及分析应用

在pH为5.0～7.6的Britton-Robinson(BR)缓冲溶液中,呋塞米(FUR)与Pd(Ⅱ)形成摩尔比1:1的配合物,进一步与乙基紫(EV)、结晶紫(CV)、甲基紫(MV)、亮绿(BG)、甲基绿(MeG)等碱性三苯甲烷染料(BTPMD)作用形成1:1的离子缔合物时,染料发生褪色反应,褪色波长分别位于595nm(EV、CV体系)、580nm(MV体系)、615nm(BG体系)和630nm(MeG体系),FUR浓度在2.0×10-7～4.0×10-6g/mL(EV体系)、3.0×10-7～8.0×10-6g/mL(CV体系)、4.0×10-7～4.0×10-6g/mL(MV体系)、4.0×10-7～7.0×10-6g/mL(BG体系)、1.2×10-6～8.0×10-6g/mL(MeG体系)范围内与褪色波长处的吸光度变化值呈良好的线性关系,摩尔吸光系数(ε)根据染料的不同在0.57×104～3.40×104L/(mol·cm)之间,灵敏度最高的EV体系的检出限(3σ)为6.0×10-8g/mL,据此建立一种测定呋塞米的新分光光度法。研究了适宜的反应条件、分析化学性质和共存物质的影响,用于尿样中呋塞米的含量测定,回收率在96.0%～106.8%之间。     

呋塞米-Pd(Ⅱ)螯合物与某些碱性三苯甲烷类染料相互作用的共振瑞利散射和共振非线性散射光谱及其分析应用

在pH4.5～7.0的Britton-Robinson(BR)缓冲溶液中,呋塞米(FUR)与Pd(Ⅱ)形成1:1的螯合阴离子,它能进一步与乙基紫(EV)、结晶紫(CV)、甲基绿(MeG)、亮绿(BG)、甲基紫(MV)等碱性三苯甲烷染料(BTPMD)阳离子通过静电引力和疏水作用形成FUR:Pd(II):BTPMD为1:1:1的离子缔合物.此时,该离子缔合反应不仅能引起吸收光谱的变化,而且更能导致共振瑞利散射(RRS)、二级散射(SOS)和倍频散射(FDS)的显著增强,其最大RRS波长分别位于324nm(EV,CV和MV体系)和340nm(BG和MeG体系),最大SOS波长分别位于550nm(EV,CV,BG和MeG体系)和530nm(MV体系),而最大FDS波长均位于392nm附近.在一定条件下三种散射增强(ΔIRRS,ΔISOS和ΔIFDS)均与呋塞米(FUR)的浓度成正比.对不同染料体系,三种方法对FUR的检出限分别在0.3～4.9ng/mL(RRS),3.2～33.1ng/mL(SOS)和9.0～85.7ng/mL(FDS)之间,均可用于痕量FUR的测定.本文研究了三元离子缔合物的形成对吸收,RRS,SOS和FDS光谱特征和强度的影响,考察了适宜的反应条件、影响因素和分析化学性质,并以RRS法为例考察了共存物质的影响.据此提出了一种高灵敏度、简便、快速测定FUR的共振光散射新方法,将其用于片剂、注射液、人血清和尿样中FUR的测定,结果满意.文中还对三元离子缔合物的组成、结构和反应机理进行了讨论.     

Development of quantitative HPTLC-densitometry methods following a model approach for transfer of TLC screening methods for pharmaceutical products of atenolol,chloramphenicol, furosemide,glibenclamide, penicillin V potassium,and praziquantel

Transfer of six thin-layer chromatography (TLC) Global Pharma Health Fund E.V. Minilab manual protocols for detecting fake drugs in pharmaceutical products to quantitative high-performance TLC (HPTLC)-densitometry methods was performed following a previously published model process. The developed and validated methods for tablets or capsules containing atenolol, chloramphenicol, furosemide, glibenclamide, penicillin V potassium, and praziquantel involved use of a limited list of inexpensive, relatively nontoxic, readily available solvents and other reagents; silica gel 60?F₂₅₄ plates; automated bandwise sample and standard solution application; ascending mobile phase development of plates in a chamber; and automated slit scanning densitometry for detection, identification, and quantification. Validation data for methods developed in an early version of the transfer model process that did not include standard addition validation are reported for pharmaceutical products containing amitriptyline HCl, amodiaquine, diphenhydramine HCl, and mebendazole.     

Development and validation of HPTLC and green HPLC methods for determination of furosemide,spironolactone and canrenone,in pure forms,tablets and spiked human plasma

Two selective and accurate chromatographic methods are presented for simultaneous quantitation of spironolactone (SP) and furosemide (FR) and canrenone (CN), the main degradation product and the main active metabolite of SP. Method A was HPTLC, where separation was completed on silica gel HPTLC F₂₅₄ plates using ethyl acetate–triethylamine–acetic acid (9:0.7:0.5, by volume) as a developing system and UV detection at 254 nm. Method B was a green isocratic RP‐HPLC utilizing a C₁₈ (4.6 × 100 mm) column, the mobile phase consisting of ethanol–deionized water (45: 55, v/v) and UV estimation at 254 nm. Adjustment of flow rate at 1 mL/min and pH at 3.5 with glacial acetic acid was done. Regarding the greenness profile, the proposed RP‐HPLC method is greener than the reported one. ICH guidelines were followed to validate the developed methods. Successful applications of the developed methods were revealed by simultaneous determination of FR, SP and CN in pure forms and plasma samples in the ranges of 0.2–2, 0.05–2.6 and 0.05–2 μg/band for method A and 5–60, 2–60 and 2–60 μg/mL for method B for FR, SP and CN, respectively.     

Interaction of glycyrrhetinic acid, furosemide and hydrochlorothiazide with bovine serum albumin and their displacement interactions: capillary electrophoresis and fluorescence quenching study

Licorice is the most widely used crude drug in traditional Chinese medicine. Glycyrrhetinic acid (GA) is the metabolite of glycyrrhizic acid, which is the main bioactive ingredient of licorice. In this work, capillary electrophoresis-frontal analysis (CE-FA) was applied to study the binding of bovine serum albumin with GA and two diuretics: furosemide (FU) and hydrochlorothiazide (HZ). The binding parameters of GA were determined by Scatchard analysis, which showed that there are two kinds of binding sites in bovine serum albumin for GA. However, the results showed that the CE-FA method was not suitable for the interaction study of FU and HZ. Therefore, utracentrifugation-CE was used to probe the binding characteristic of these two drugs and the results showed only one kind of binding site for them under the studied conditions. Displacement interactions between these drugs were also investigated by utracentrifugation-CE method and the results showed that GA hardly displaces HZ while it can slightly displace FU and FU can slightly displace HZ. For comparison, the binding of these drugs was also studied by the fluorescence quenching method and the data were processed by the Stern-Volmer quenching equation. Results showed that the binding constants were basically consistent for two methods for all drugs studied. The number of binding sites on one protein molecule was well consistent for FU and HZ while it was quite different for GA.     

The Influence of β-Cyclodextrins on the Solubility of Furosemide

Furosemide (F) is practically insoluble in water (10.26 mg/100 mL).Different -cyclo- dextrins (-CD derivatives) were applied ashost to improve the solubility of furosemide as guest molecule via inclusioncomplex formation. Various molar ratios of F : -CD derivatives (1 :1/2, 1 : 1 and 1 : 2) and different preparative methods (physical mixing,kneading, precipitation, spray-drying and freeze-drying) were used. Theincrease in the dissolution characteristics and the solubility of furosemidedepends on the type of -CD derivative, on the furosemide concentrationin the product and on the method of preparation. The inclusion complexesformed between the hosts and the guest were investigated by XRD, IR, and¹H-NMR spectral methods.     

High-performance liquid chromatography method development and validation for simultaneous determination of five model compounds, antipyrine, metoprolol, ketoprofen, furosemide and phenol red, as a tool for the standardization of rat in situ intestinal permeability studies using timed wavelength detection

A simple, precise, accurate and rugged reversed-phase high-performance liquid chromatography (HPLC) method has been developed and validated for the simultaneous determination of five permeability model compounds, viz. antipyrine, metoprolol, ketoprofen, furosemide and phenol red. The method was intended to standardize rat in situ single-pass intestinal perfusion studies to assess the intestinal permeability of drugs in the market as well as new chemical entities. Optimum resolution was achieved by gradient elution on a Symmetry Shield C-18 analytical column with the mobile phase consisting of a mixture of aqueous potassium dihydrogen orthophosphate (pH 5.5; 0.01 m) and methanol at a flow rate of 1.5 mL/min. The retention times of antipyrine, metoprolol, ketoprofen, phenol red and furosemide were about 9, 12, 13, 16 and 17 min, respectively. Data acquisition was carried out using a photo diode array detector in the wavelength range 210-600 nm. Extraction of chromatograms was carried out by timed wavelength. Data obtained in all studies indicated that the method was suitable for the intended purpose. The validated method was found to be linear and precise in the working range. Suitability of storage under various conditions and freeze/thaw impact at cold temperature were established to ensure complete sample recovery without any stability issues. Recovery very close to the spiked amounts indicated that the method was highly accurate and suitable for use on routine basis.     

Freeze-Dried Complexes of Furosemide with β-Cyclodextrin Derivatives

A freeze-drying method was used to prepare complexes of furosemide (guest) with three derivatives of -cyclodextrin (hosts) in different molecular ratios in order to increase the aqueous solubility and rate of dissolution of the drug, and also to study the influence of this method on different parameters of the guest and the host, such as the diffusion rate constant and the partition coefficient, and additionally the surface tension activity of the host (if any). The hosts were found to have significant, increasing effects on the solubility and the rate of dissolution of furosemide. X-ray diffraction confirmed the host–guest interaction, in support of the earlier results. The freeze-drying method increased the diffusion rate of the drug in complex form, while the partition coefficient varied with the type of -cyclodextrin in the product. It is well known that CD derivatives are highly surface active which gives rise to their hemolytic action. Our observations showed that their presence with furosemide in complex form might decrease (if not diminish) the hemolytic action.